Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Self-crosslinked human serum albumin nanocarriers for systemic delivery of polymerized siRNA to tumors

Authors
Son, SoheeSong, SeungyongLee, So JinMin, SolkiKim, Sun AhYhee, Ji YoungHuh, Myung SookKwon, Ick ChanJeong, Seo YoungByun, YoungroKim, Sun HwaKim, Kwangmeyung
Issue Date
12월-2013
Publisher
ELSEVIER SCI LTD
Keywords
Cancer therapy; RNAi; Polymerized siRNA; Protein based carrier; Human serum albumin
Citation
BIOMATERIALS, v.34, no.37, pp.9475 - 9485
Indexed
SCIE
SCOPUS
Journal Title
BIOMATERIALS
Volume
34
Number
37
Start Page
9475
End Page
9485
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/101356
DOI
10.1016/j.biomaterials.2013.08.085
ISSN
0142-9612
Abstract
The safe and effective systemic delivery of siRNA is a prerequisite for the successful development of siRNA-based cancer therapeutics. For the enhanced delivery of siRNA, cationic lipids and polymers have been widely used as siRNA carriers to form electrolyte complexes with anionic siRNA. However, the considerable toxicity of strong cationic-charged molecules hampers their clinical use. In this study, we utilized human serum albumin (HSA), which is the most abundant of the plasma proteins, as a siRNA carrier for systemic tumor-targeted siRNA delivery. Both HSA and siRNA molecules were thiol-introduced to improve the binding affinity for each other. The resulting thiolated HSA (tHSA) and polymerized siRNA (psi) formed stable nanosized complexes (psi-tHSAs) by chemical crosslinking and self-crosslinking. After internalization, the psi-tHSAs showed target gene silencing activity in vitro comparable to conventional Lipofectamine (TM)-siRNA complexes, without remarkable cytotoxicity. After intravenous injection in tumor-bearing mice, psi-tHSAs accumulated specifically at the tumor sites, leading to efficient gene silencing in the tumors in a sequential manner. The therapeutic VEGF siRNA was loaded into psi-tHSAs, which significantly inhibited tumor-related angiogenesis in PC-3 tumor xenografts and resulted in retarding the growth of PC-3 tumors. The results showed that self-crosslinked psi-tHSA nanocarriers might provide a promising approach for the systemic siRNA therapy of various human cancers. (C) 2013 Elsevier Ltd. All rights reserved.
Files in This Item
There are no files associated with this item.
Appears in
Collections
Graduate School > KU-KIST Graduate School of Converging Science and Technology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE